A detailed history of Logos Global Management LP transactions in Merus N.V. stock. As of the latest transaction made, Logos Global Management LP holds 575,000 shares of MRUS stock, worth $26.2 Million. This represents 3.8% of its overall portfolio holdings.

Number of Shares
575,000
Previous 850,000 32.35%
Holding current value
$26.2 Million
Previous $50.3 Million 42.88%
% of portfolio
3.8%
Previous 4.72%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$47.19 - $58.84 $13 Million - $16.2 Million
-275,000 Reduced 32.35%
575,000 $28.7 Million
Q2 2024

Aug 14, 2024

BUY
$39.81 - $60.2 $33.8 Million - $51.2 Million
850,000 New
850,000 $50.3 Million
Q3 2023

Nov 14, 2023

BUY
$20.13 - $27.29 $4.93 Million - $6.69 Million
245,000 New
245,000 $5.78 Million

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.09B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.